Metabolic benefits of six-month thiamine supplementation in patients with and without diabetes mellitus type 2

Clinical Medicine Insights: Endocrinology and Diabetes

Volumn 7, Issue , 2014, Pages

  Al Attas, Omar ^a,b   Al Daghri, Nasser ^a,b   Alokail, Majed ^a,b   Abd Alrahman, Sherif ^b   Vinodson, Benjamin ^b   Sabico, Shaun ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes mellitus type 2; Saudi; Supplements; Thiamine

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; THIAMINE; THIAMINE PHOSPHATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY MASS; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

EID: 84893362924     PISSN: 11795514     EISSN: 11795514     Source Type: Journal    
DOI: 10.4137/CMED.S13573     Document Type: Article

References (17)

1. Al-Daghri NM, Al-Attas OS, Alokail MS, et al. Diabetes Mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med. 2011;9:76.
2. El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, et al. Risk factors for diabetic retinopathy among Saudi Diabetics. Int Ophthalmolol. 1998;22:155-161.
3. Parving HH, Harrington JT, Lewis J, et al. Diabetic nephropathy: prevention and treatment. Kidney Internat. 2001;60:2041-2055.
4. Thornalley PJ. Cell activation by glycated proteins, AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol. 1998;44:1013-1023.
5. Al-Attas OS, Al-Daghri NM, Alfadda A, et al. Blood thiamine and derivatives as measured by high performance liquid chromatography: levels and associations in DM patients with varying degrees of microalbuminuria. J Endocr Invest. 2012;35:951-956.
6. Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev. 2005;1:287-298.
7. Rabbani N, Thornalley PJ. Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy. Diabetes Obes Metab. 2001;13:577-583.
8. Hooper PL, Hooper EM, Hunt WC, et al. Vitamins, lipids and lipoproteins in a healthy elderly population. Int J Vitamin Nutr Res. 1983;53:412-419.
9. Naveed AK, Qamar T, Ahmad I, et al. Effect of thiamine on lipid profile in diabetic rats. J Coll Physicians Surg Pak. 2009;19:165-168.
10. Karachalias N, Babaei-Jadidi R, Kupich C, et al. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats. Ann N Y Acad Sci. 2005;1043:777-783.
11. Gonzalez-Ortiz M, Martinez-Abundis E, Robles-Cervantes JA, et al. Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-naïve patients with type 2 diabetes. Eur J Nutr. 2011;50:145-149.
12. Babaei-Jadidi R, Karachalias N, Kupich C, et al. High-dose thiamine therapy counters dyslipidemia in streptozotocin-induced diabetic rats. Diabetologia. 2004;47:2235-2246.
13. Alkhalaf A, Klooster A, van Oeveren W, et al. A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy. Diabetes Care. 2010;33:1598-1601.
14. Fraser DA, Diep LM, Hovden IA, et al. The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care. 2010;35:1095-1097.
15. Tanaka T, Kono T, Terasaki F, et al. Thiamine prevents obesity and obesity-associated metabolic disorders in OLETF rats. J Nutr Sci Vitaminol (Tokyo). 2010;56:335-346.
16. Bakker SJ, Hoogeveen EK, Nijpels G, et al. The association of dietary fibers with glucose tolerance is partly explained by concomitant intake of thiamine: the Hoorn Study. Diabetologia. 1998;41:1168-1175.
17. Vindedzis SA, Stanton KG, Sherriff JL, et al. Thiamine deficiency in diabetes-is diet relevant? Diab Vasc Dis Res. 2008;5:215.